Skip To Main Content
Silver Spring Maryland on Muck Rack

Silver Spring Maryland

As seen in: Color Research & Application, PLOS
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Silver Spring

Contact Silver Spring, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Effects of N-glycan modifications on spike expression, virus infectivity, and neutralization sensitivity in ancestral compared to Omicron SARS-CoV-2 variants

|
By Sabrina Lusvarghi, Silver Spring Maryland, Charles B. Stauft, Russell Vassell, PLOS Pathogens
| PLOS
Loading metrics Open Access Peer-reviewed Research Article ? This is an uncorrected proof. Citation: Lusvarghi S, Stauft CB, Vassell R, Williams B, Baha H, Wang W, et al. (2023) Effects of N-glycan modifications on spike expression, virus infectivity, and neutralization sensitivity in ancestral compared to Omicron SARS-CoV-2 variants. PLoS Pathog 19(11): e1011788. https://doi.org/10.1371/journal.ppat.1011788 Editor: Penny L.
Open in Who Shared Issue with article?

Review article: consensus guidelines: best practices for detection, assessment and management of suspected acute drug‐induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis - Regev - - Alimentary Pharmacology & Thera

|
By Melissa Palmer, Arie Regev, Mark I. Avigan, Silver Spring Maryland
| Color Research & Application Verified
Summary Background The last decade has seen a rapid growth in the number of clinical trials enrolling patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis (NASH). Due to the underlying chronic liver disease, patients with NASH often require different approaches to the assessment and management of suspected drug‐induced liver injury (DILI) compared to patients with healthy livers.
Open in Who Shared Issue with article?
See all 2 articles